Skip to main content
SpringerLink
Log in

A Prospective Study of 2-[18F] Fluoro-2-Deoxy-D-Glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen Levels

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer Statistics, 2001. CA Cancer J Clin 2001; 51: 15–36.

    CAS  PubMed  Google Scholar 

  2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8–31.

    CAS  PubMed  Google Scholar 

  3. Minton JP, Hoehn JL, Gerber DM, et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985; 55: 1284–90.

    PubMed  CAS  Google Scholar 

  4. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938–46.

    CAS  PubMed  Google Scholar 

  5. Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin 1995; 45: 50–62.

    PubMed  CAS  Google Scholar 

  6. Goldberg RM, Fleming TR, Tangen CM, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998; 129: 27–35.

    CAS  PubMed  Google Scholar 

  7. Jarnagin WR, Fong Y, KyA, Schwartz LH, Paty PB, Cohen AM, Blumgart LH. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg 1999; 188: 33–42.

    PubMed  CAS  Google Scholar 

  8. Girard P, Ducreux M, Baldeyrou P, et al. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol 1996; 14: 2047–53.

    PubMed  CAS  Google Scholar 

  9. Desch CE, Benson AB, Smith TJ, et al. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol 1999; 17: 1312.

    CAS  PubMed  Google Scholar 

  10. Sardi A, Nieroda CA, Siddiqi MA, Minton JP, Martin EW. Carcinoembryonic antigen directed multiple surgical procedures for recurrent colon cancer confined to the liver. Am Surg 1990; 56: 255–9.

    PubMed  CAS  Google Scholar 

  11. Martin EW, Minton JP, Carey LC. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Ann Surg 1985; 202: 310–7.

    Article  PubMed  Google Scholar 

  12. Larson SM, Divgi CR, Scott AM. Overview of clinical radioimmunodetection of human tumors. Cancer 1994; 73: 832–5.

    PubMed  CAS  Google Scholar 

  13. Larson SM, Divgi CR, Scott A, et al. Current status of radioimmunotherapy. Nucl Med Biol 1994; 21: 785–92.

    PubMed  CAS  Google Scholar 

  14. Akhurst T, Larson SM. Positron emission tomography imaging of colorectal cancer. Semin Oncol 1999; 26: 577–83.

    PubMed  CAS  Google Scholar 

  15. Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR. PET and [18F]-FDG in oncology: a clinical update. Nucl Med Biol 1996; 23: 717–35.

    PubMed  CAS  Google Scholar 

  16. Delbeke D. Oncological applications of FDG PET imaging. J Nucl Med 1999; 40: 1706–15.

    PubMed  CAS  Google Scholar 

  17. Pauwels EK, Sturm EJ, Bombardieri E, Cleton FJ, Stokkel MP. Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 2000; 126: 549–59.

    PubMed  CAS  Google Scholar 

  18. Moffat FL, Pinsky CM, Hammershaimb L, et al. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab′ antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group. J Clin Oncol 1996; 14: 2295–305.

    PubMed  Google Scholar 

  19. Stomper PC, D’Souza DJ, Bakshi SP, Rodriguez-Bigas M, Burke PA, Petrelli NJ. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT. Radiology 1995; 197; 688–92.

    PubMed  Google Scholar 

  20. Patt YZ, Podoloff DA, Curley S, et al. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels. J Clin Oncol 1994; 12: 489–95.

    PubMed  CAS  Google Scholar 

  21. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235–8.

    CAS  PubMed  Google Scholar 

  22. Jacobson M, Levkovitz R, Ben-Tal A, et al. Enhanced 3D PET OSEM reconstruction using inter-update Metz filtering. Phys Med Biol 2000; 45: 2417–39.

    PubMed  CAS  Google Scholar 

  23. Alexander HR Jr, Bartlett DL, Libutti SK, Fraker DL, Moser T, Rosenberg SA. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 1998; 16: 1479–89.

    PubMed  CAS  Google Scholar 

  24. Alexander HR Jr, Bartlett DL, Libutti SK. Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver. Cancer J Sci Am 1998; 4: 2–11.

    PubMed  Google Scholar 

  25. Alexander HR, Libutti SK, Bartlett DL, Puhlmann M, Fraker DL, Bachenheimer LC. A phase I–II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2000; 6: 3062–70.

    PubMed  CAS  Google Scholar 

  26. Bartlett DL, Buell JF, Libutti SK, et al. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis [published erratum appears in Cancer 1998; 83: 2241]. Cancer 1998; 83: 1251–61.

    PubMed  CAS  Google Scholar 

  27. Bartlett DL, Libutti SK, Figg WD, Fraker DL, Alexander HR. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Surgery 2001; 129: 176–87.

    Article  CAS  PubMed  Google Scholar 

  28. Minton J, Chevinsky AH. CEA directed second-look surgery for colon and rectal cancer. Ann Chir Gynaecol 1989; 78: 32–7.

    PubMed  CAS  Google Scholar 

  29. Minton JP. Technical surgical considerations for CEA directed second-look operations and hepatic tumor excision. Semin Surg Oncol 1991; 7: 143–5.

    PubMed  CAS  Google Scholar 

  30. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000; 30: 150–85.

    PubMed  CAS  Google Scholar 

  31. Blomqvist L, Holm T, Goranson H, Jacobsson H, Ohlsen H, Larsson SA. MR imaging, CT and CEA scintigraphy in the diagnosis of local recurrence of rectal carcinoma. Acta Radiol 1996; 37: 779–84.

    Article  PubMed  CAS  Google Scholar 

  32. Buccheri G, Biggi A, Ferrigno D, et al. Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer. Thorax 1996; 51: 359–63.

    Article  PubMed  CAS  Google Scholar 

  33. Hughes K, Pinsky CM, Petrelli NJ, et al. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer. Ann Surg 1997; 226: 621–31.

    PubMed  CAS  Google Scholar 

  34. Hoh CK, Hawkins RA, Glaspy JA, et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993; 17: 582–9.

    PubMed  CAS  Google Scholar 

  35. Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998; 227: 319–23.

    PubMed  CAS  Google Scholar 

  36. Jarv V, Blomqvist L, Holm T, Ringertz H, Jacobsson H. Added value of CEA scintigraphy in the detection of recurrence of rectal carcinoma. Acta Radiol 2000; 41: 629–33.

    PubMed  CAS  Google Scholar 

  37. Lechner P, Lind P, Binter G, Cesnik H. Anticarcinoembryonic antigen immunoscintigraphy with a 99mTc-Fab′ fragment (Immu 4) in primary and recurrent colorectal cancer. A prospective study. Dis Colon Rectum 1993; 36: 930–5.

    PubMed  CAS  Google Scholar 

  38. Willkomm P, Bender H, Bangard M, Decker P, Grunwald F, Biersack HJ. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med 2000; 41: 1657–63.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgery Branch SKL, HRA, DLB, KK, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland

    Steven K Libutti MD, H Richard Alexander Jr, MD, David L Bartlett MD & Karen Kranda RN

  2. Nuclear Medicine SLB, MW, FJ, RDN, JAC, the Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

    Peter Choyke MD, Stephen L Bacharach PhD, Millie Whatley RNMT, Frederic Jousse MD, Ronald D Neumann MD & Jorge A Carrasquillo MD

  3. the Department of Positron Emission Tomography WCE, the Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

    William C Eckelman PhD

  4. National Institutes of Health/NCI, Building 10, Room 3C428, Bethesda, MD, 20892-1502

    Steven K Libutti MD

Authors
  1. Steven K Libutti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Richard Alexander Jr, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Choyke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David L Bartlett MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephen L Bacharach PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Millie Whatley RNMT
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Frederic Jousse MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. William C Eckelman PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Karen Kranda RN
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ronald D Neumann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jorge A Carrasquillo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven K Libutti MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Libutti, S.K., Alexander, H.R., Choyke, P. et al. A Prospective Study of 2-[18F] Fluoro-2-Deoxy-D-Glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen Levels. Ann Surg Oncol 8, 779–786 (2001). https://doi.org/10.1007/s10434-001-0779-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0779-9

Keywords

Search

Navigation